Are men with favorable intermediate-risk prostate cancer candidates for active surveillance?

被引：0
|
作者：
Raldow, Ann Caroline
Zhang, Danjie
Chen, Ming-Hui
Braccioforte, Michelle H.
Moran, Brian Joseph
D'Amico, Anthony Victor
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Univ Connecticut, Storrs, CT USA
[3] Prostate Canc Fdn Chicago, Westmont, IL USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.82
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
82
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Is active surveillance safe for patients with intermediate-risk prostate cancer?
    Chung, Hoseok
    Shin, Bo Sung
    Nam, Deok-Hyun
    Chung, Hoseok
    Kim, Myung Ki
    Jung, Seung Il
    Kang, Taek Won
    Kwon, Dong Deuk
    BJU INTERNATIONAL, 2015, 116 : 4 - 4
  • [22] Active surveillance for intermediate-risk prostate cancer: yes, but for whom?
    Overland, Maya R.
    Washington, Samuel L., III
    Carroll, Peter R.
    Cooperberg, Matthew R.
    Herlemann, Annika
    CURRENT OPINION IN UROLOGY, 2019, 29 (06) : 605 - 611
  • [23] PROSTATE CANCER Time for active surveillance of intermediate-risk disease?
    Ahmed, Hashim U.
    NATURE REVIEWS UROLOGY, 2013, 10 (01) : 6 - 8
  • [24] Active surveillance in low- and intermediate-risk prostate cancer
    Cerbone, Linda
    Regine, Giovanni
    Calabro, Fabio
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 582 - 583
  • [25] Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice
    Sayyid, Rashid K.
    Klotz, Laurence
    Benton, John Z.
    Ma, Merry
    Woodruff, Phillip
    Satkunasivam, Raj
    Terris, Martha K.
    Wallis, Christopher J. D.
    Klaassen, Zachary
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (01): : E7 - E14
  • [26] Active Surveillance for Men with Intermediate Risk Prostate Cancer
    Agrawal, Vishesh
    Ma, Xiaoyue
    Hu, Jim C.
    Barbieri, Christopher E.
    Nagar, Himanshu
    JOURNAL OF UROLOGY, 2021, 205 (01): : 115 - 121
  • [27] THE USE AND OUTCOMES OF MEN WITH NCCN FAVORABLE INTERMEDIATE RISK PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE
    Paudel, Roshan
    Madan, Raghav
    Qi, Ji
    Cher, Michael
    Lane, Brian
    George, Arvin
    Semerjian, Alice
    Ginsburg, Kevin
    JOURNAL OF UROLOGY, 2022, 207 (05): : E745 - E745
  • [28] A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort
    Kuhlmann, Paige K.
    Oyekunle, Taofik
    Klaassen, Zachary
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Terris, Martha K.
    Freedland, Stephen J.
    CANCER MEDICINE, 2023, 12 (09): : 10931 - 10938
  • [29] Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer
    Barzell, Winston E.
    Melamed, Myron R.
    Cathcart, Paul
    Moore, Caroline M.
    Ahmed, Hashim U.
    Emberton, Mark
    JOURNAL OF UROLOGY, 2012, 188 (03): : 762 - 767
  • [30] Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
    Blas, Leandro
    Shiota, Masaki
    Eto, Masatoshi
    CANCERS, 2022, 14 (17)
12345